THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 144 filers reported holding THERAPEUTICSMD INC in Q4 2017. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $5,000 | -96.6% | 13,129 | -96.9% | 0.00% | – |
Q4 2021 | $148,000 | -83.9% | 417,390 | -66.4% | 0.00% | -100.0% |
Q3 2021 | $921,000 | -61.9% | 1,242,386 | -38.9% | 0.00% | 0.0% |
Q2 2021 | $2,420,000 | -33.4% | 2,033,295 | -25.0% | 0.00% | -66.7% |
Q1 2021 | $3,633,000 | +1734.8% | 2,711,504 | +1553.6% | 0.00% | – |
Q4 2020 | $198,000 | -0.5% | 163,977 | +30.3% | 0.00% | – |
Q3 2020 | $199,000 | -79.1% | 125,888 | -83.5% | 0.00% | -100.0% |
Q2 2020 | $952,000 | +1342.4% | 761,553 | +4072.4% | 0.00% | – |
Q3 2019 | $66,000 | -82.7% | 18,252 | -87.6% | 0.00% | -100.0% |
Q2 2019 | $382,000 | -97.7% | 146,865 | -95.7% | 0.00% | -96.0% |
Q1 2019 | $16,448,000 | +51.5% | 3,377,338 | +18.6% | 0.02% | +47.1% |
Q4 2018 | $10,854,000 | +301.1% | 2,848,750 | +590.6% | 0.02% | +466.7% |
Q3 2018 | $2,706,000 | +280.1% | 412,491 | +206.4% | 0.00% | +200.0% |
Q3 2017 | $712,000 | -88.2% | 134,608 | -84.0% | 0.00% | -90.9% |
Q1 2017 | $6,057,000 | -61.8% | 841,286 | -69.4% | 0.01% | -66.7% |
Q4 2016 | $15,845,000 | +118.4% | 2,746,085 | +157.8% | 0.03% | +175.0% |
Q3 2016 | $7,255,000 | +109.6% | 1,065,333 | +161.6% | 0.01% | +50.0% |
Q2 2016 | $3,462,000 | -55.6% | 407,275 | -66.6% | 0.01% | -60.0% |
Q1 2016 | $7,795,000 | -68.6% | 1,217,984 | -49.1% | 0.02% | -61.5% |
Q4 2015 | $24,811,000 | +53.6% | 2,392,599 | -13.2% | 0.05% | +67.7% |
Q3 2015 | $16,150,000 | -32.5% | 2,755,852 | -9.5% | 0.03% | -31.1% |
Q2 2015 | $23,923,000 | +40.4% | 3,043,619 | +8.1% | 0.04% | +40.6% |
Q1 2015 | $17,034,000 | +71.4% | 2,815,506 | +26.1% | 0.03% | +52.4% |
Q4 2014 | $9,940,000 | -6.1% | 2,233,619 | -2.1% | 0.02% | -22.2% |
Q3 2014 | $10,584,000 | +17.1% | 2,281,007 | +11.5% | 0.03% | +8.0% |
Q2 2014 | $9,039,000 | -35.0% | 2,045,000 | -7.3% | 0.02% | -37.5% |
Q1 2014 | $13,914,000 | +46.6% | 2,205,000 | +21.0% | 0.04% | +33.3% |
Q4 2013 | $9,493,000 | +72.2% | 1,822,000 | -3.2% | 0.03% | +66.7% |
Q3 2013 | $5,513,000 | +9.0% | 1,881,500 | +12.7% | 0.02% | +12.5% |
Q2 2013 | $5,060,000 | – | 1,670,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,460,225 | $24,914,000 | 4.95% |
Newtyn Management, LLC | 1,800,000 | $12,960,000 | 1.95% |
1492 Capital Management LLC | 222,485 | $1,602,000 | 1.25% |
SANDERS MORRIS HARRIS LLC | 967,200 | $6,964,000 | 1.18% |
MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,296,000 | 1.15% |
SPHERA FUNDS MANAGEMENT LTD. | 580,000 | $4,176,000 | 0.82% |
Rock Springs Capital Management LP | 1,600,000 | $11,520,000 | 0.66% |
STONERIDGE INVESTMENT PARTNERS LLC | 467,425 | $3,365,000 | 0.45% |
Capital Impact Advisors, LLC | 157,411 | $1,133,000 | 0.45% |
GILDER GAGNON HOWE & CO LLC | 3,059,690 | $22,030,000 | 0.37% |